Trupanion (NASDAQ:TRUP) Stock Price Up 6.1%

Trupanion, Inc. (NASDAQ:TRUPGet Rating)’s share price rose 6.1% during mid-day trading on Wednesday . The stock traded as high as $67.39 and last traded at $67.39. Approximately 1,949 shares traded hands during trading, a decline of 100% from the average daily volume of 420,318 shares. The stock had previously closed at $63.50.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on TRUP shares. Northland Securities cut their price target on shares of Trupanion from $80.00 to $70.00 in a research report on Thursday, August 4th. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $80.00 to $69.00 in a research report on Thursday, August 4th. Evercore ISI decreased their price target on shares of Trupanion to $85.00 in a report on Tuesday, August 9th. Canaccord Genuity Group reduced their target price on Trupanion from $100.00 to $90.00 in a report on Friday, August 5th. Finally, Jefferies Financial Group assumed coverage on Trupanion in a research note on Wednesday. They issued a “buy” rating and a $77.00 target price for the company. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $88.71.

Trupanion Stock Down 9.4 %

The firm has a market capitalization of $2.40 billion, a P/E ratio of -66.13 and a beta of 1.95. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.78 and a current ratio of 1.78. The firm’s 50-day moving average is $68.41 and its 200 day moving average is $70.36.

Trupanion (NASDAQ:TRUPGet Rating) last released its quarterly earnings results on Wednesday, August 3rd. The financial services provider reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.10). The firm had revenue of $219.41 million during the quarter, compared to analyst estimates of $216.63 million. Trupanion had a negative net margin of 4.53% and a negative return on equity of 10.62%. As a group, equities research analysts predict that Trupanion, Inc. will post -1.03 EPS for the current fiscal year.

Insider Buying and Selling at Trupanion

In other news, CEO Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 14th. The shares were sold at an average price of $65.57, for a total transaction of $262,280.00. Following the completion of the transaction, the chief executive officer now directly owns 857,109 shares of the company’s stock, valued at approximately $56,200,637.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $65.57, for a total value of $262,280.00. Following the completion of the transaction, the chief executive officer now owns 857,109 shares of the company’s stock, valued at $56,200,637.13. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Michael Doak sold 700 shares of the firm’s stock in a transaction on Tuesday, July 5th. The shares were sold at an average price of $60.00, for a total transaction of $42,000.00. Following the completion of the transaction, the director now directly owns 1,007 shares of the company’s stock, valued at approximately $60,420. The disclosure for this sale can be found here. In the last quarter, insiders have sold 28,207 shares of company stock worth $1,934,952. Corporate insiders own 5.86% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Crossmark Global Holdings Inc. grew its position in Trupanion by 24.4% in the first quarter. Crossmark Global Holdings Inc. now owns 7,585 shares of the financial services provider’s stock valued at $676,000 after purchasing an additional 1,490 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Trupanion by 41.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 231,780 shares of the financial services provider’s stock valued at $30,602,000 after acquiring an additional 67,442 shares during the period. FDx Advisors Inc. grew its position in shares of Trupanion by 28.1% in the 1st quarter. FDx Advisors Inc. now owns 5,872 shares of the financial services provider’s stock valued at $523,000 after acquiring an additional 1,289 shares during the period. McIlrath & Eck LLC grew its position in shares of Trupanion by 14.9% in the 1st quarter. McIlrath & Eck LLC now owns 1,418 shares of the financial services provider’s stock valued at $126,000 after acquiring an additional 184 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Trupanion by 2.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 251,682 shares of the financial services provider’s stock valued at $33,230,000 after acquiring an additional 5,061 shares during the period. Institutional investors own 97.85% of the company’s stock.

Trupanion Company Profile

(Get Rating)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

See Also

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.